3 Matching Annotations
  1. Mar 2026
    1. Absolute size thresholds for degenerative aneurysms: [1][3][5]

      Ascending aorta/aortic root: ≥5.5 cm

      Descending thoracic aorta: ≥6.0 cm (or 5.5 cm if favorable anatomy for TEVAR)

      Thoracoabdominal aorta: ≥6.0 cm

      Lower thresholds apply for: [3]

      Marfan syndrome or genetic conditions: 4.0-5.0 cm depending on condition

      Bicuspid aortic valve: 5.0-5.5 cm

      Rapid growth: >0.5 cm/year

      Concomitant cardiac surgery: >4.5 cm if undergoing aortic valve surgery

      Immediate surgical evaluation: [5]

      Any symptomatic aneurysm regardless of size (chest/back pain, dysphagia, hoarseness, hemoptysis)

      Acute complications (dissection, rupture, malperfusion)

      Post-Repair Surveillance

      After TEVAR: CT at 1 month, 12 months, then annually if stable. [1]

      After open repair: CT or MRI within 1 year, then every 5 years if no residual aortopathy. Annual imaging if residual disease or abnormal findings.

  2. Nov 2021
  3. Jun 2021